Thomas is a Principal at Ysios Capital, where he is responsible for identifying and evaluating investment opportunities. Prior to joining Ysios, Thomas was Senior Associate at Gimv within the Health & Care team working out of the Antwerp office. He was focused on early-stage Life Sciences investments. Thomas co-led the investments in Anjarium Biosciences and Kinaset Therapeutics and was involved with portfolio companies Fire1, ONWARD (Euronext – ONWD), Biotalys (Euronext – BTLS), JenaValve, and Breath Therapeutics (sold to Zambon).
Thomas holds a master’s degree in bioengineering and applied economics, both from the University of Ghent.